The Toxicology Investigators Consortium Case Registry—the 2016 Experience

On behalf of the Toxicology Investigators Consortium Study Group

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Toxicology Investigators Consortium (ToxIC) Case Registry was established by the American College of Medical Toxicology in 2010. The Registry contains data from participating sites with the agreement that all bedside medical toxicology consultations will be entered. Currently, 83% of accredited medical toxicology fellowship programs in the USA participate. The Registry continues to grow each year, and as of 31 December 2016, a new milestone was reached, with more than 50,000 cases reported since its inception. The objective of this seventh annual report is to summarize the Registry’s 2016 data and activity with its additional 8529 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2016. Detailed data was collected from these cases and aggregated to provide information which includes the following: demographics (age, gender, race, ethnicity, HIV status), reason for medical toxicology evaluation (intentional pharmaceutical exposure, envenomation, withdrawal from a substance), agent and agent class, clinical signs and symptoms (vital sign abnormalities, organ system dysfunction), treatments and antidotes administered, fatality and life support withdrawal data. Fifty percent of cases involved females, and adults aged 19–65 were the most commonly reported. There were 86 patients (1.0%) with HIV-positive status known. Non-opioid analgesics were the most commonly reported agent class, with acetaminophen the most common agent reported. There were 126 fatalities reported in 2016 (1.5% of cases). Major trends in demographics and exposure characteristics remained similar overall with past years’ reports. While treatment interventions were commonly required, fatalities were rare.

Original languageEnglish (US)
Pages (from-to)203-226
Number of pages24
JournalJournal of Medical Toxicology
Volume13
Issue number3
DOIs
StatePublished - Aug 1 2017

Fingerprint

Toxicology
Research Personnel
Registries
Antidotes
Acetaminophen
Demography
HIV
Analgesics
Annual Reports
Vital Signs
Signs and Symptoms
Referral and Consultation
Pharmaceutical Preparations
Databases
Therapeutics

Keywords

  • Epidemiology
  • Medical toxicology
  • Overdose
  • Poisonings

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

The Toxicology Investigators Consortium Case Registry—the 2016 Experience. / On behalf of the Toxicology Investigators Consortium Study Group.

In: Journal of Medical Toxicology, Vol. 13, No. 3, 01.08.2017, p. 203-226.

Research output: Contribution to journalArticle

On behalf of the Toxicology Investigators Consortium Study Group 2017, 'The Toxicology Investigators Consortium Case Registry—the 2016 Experience', Journal of Medical Toxicology, vol. 13, no. 3, pp. 203-226. https://doi.org/10.1007/s13181-017-0627-3
On behalf of the Toxicology Investigators Consortium Study Group. / The Toxicology Investigators Consortium Case Registry—the 2016 Experience. In: Journal of Medical Toxicology. 2017 ; Vol. 13, No. 3. pp. 203-226.
@article{5b9c7a464474474bb6541a7108d39e0a,
title = "The Toxicology Investigators Consortium Case Registry—the 2016 Experience",
abstract = "The Toxicology Investigators Consortium (ToxIC) Case Registry was established by the American College of Medical Toxicology in 2010. The Registry contains data from participating sites with the agreement that all bedside medical toxicology consultations will be entered. Currently, 83{\%} of accredited medical toxicology fellowship programs in the USA participate. The Registry continues to grow each year, and as of 31 December 2016, a new milestone was reached, with more than 50,000 cases reported since its inception. The objective of this seventh annual report is to summarize the Registry’s 2016 data and activity with its additional 8529 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2016. Detailed data was collected from these cases and aggregated to provide information which includes the following: demographics (age, gender, race, ethnicity, HIV status), reason for medical toxicology evaluation (intentional pharmaceutical exposure, envenomation, withdrawal from a substance), agent and agent class, clinical signs and symptoms (vital sign abnormalities, organ system dysfunction), treatments and antidotes administered, fatality and life support withdrawal data. Fifty percent of cases involved females, and adults aged 19–65 were the most commonly reported. There were 86 patients (1.0{\%}) with HIV-positive status known. Non-opioid analgesics were the most commonly reported agent class, with acetaminophen the most common agent reported. There were 126 fatalities reported in 2016 (1.5{\%} of cases). Major trends in demographics and exposure characteristics remained similar overall with past years’ reports. While treatment interventions were commonly required, fatalities were rare.",
keywords = "Epidemiology, Medical toxicology, Overdose, Poisonings",
author = "{On behalf of the Toxicology Investigators Consortium Study Group} and Farrugia, {Lynn A.} and Rhyee, {Sean H.} and Calello, {Diane P.} and Campleman, {Sharan L.} and Riederer, {Anne M.} and Malashock, {Hannah R.} and Anthony Pizon and Timothy Wiegand and Wax, {Paul M.} and Jeffrey Brent and Aks, {S. E.} and Algren, {D. A.} and D. Alwasiyah and G. Beauchamp and Y. Bentur and Beuhler, {M. C.} and Boyle, {K. L.} and Bruccoleri, {R. E.} and Burns, {M. M.} and A. Cahana and Cannon, {R. D.} and Caravati, {E. M.} and Carey, {J. L.} and N. Chhabra and J. Chomin and Christian, {M. R.} and K. Conner and Cook, {M. D.} and Cumpston, {K. L.} and V. Dissanayake and Dribben, {W. H.} and Eisenga, {B. H.} and Engebretsen, {K. M.} and D. Falkowitz and A. Farkas and A. Fenton and Froberg, {B. A.} and Furmaga, {J. F.} and M. Ganetsky and F. Garlich and Geib, {A. J.} and R. Gorodetsky and S. Greene and Greller, {H. A.} and Gummin, {D. D.} and K. Hart and Hendrickson, {R. G.} and S. Hernandez and Hoyte, {C. O.} and Kirschner, {Ronald I}",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s13181-017-0627-3",
language = "English (US)",
volume = "13",
pages = "203--226",
journal = "Journal of Medical Toxicology",
issn = "1556-9039",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - The Toxicology Investigators Consortium Case Registry—the 2016 Experience

AU - On behalf of the Toxicology Investigators Consortium Study Group

AU - Farrugia, Lynn A.

AU - Rhyee, Sean H.

AU - Calello, Diane P.

AU - Campleman, Sharan L.

AU - Riederer, Anne M.

AU - Malashock, Hannah R.

AU - Pizon, Anthony

AU - Wiegand, Timothy

AU - Wax, Paul M.

AU - Brent, Jeffrey

AU - Aks, S. E.

AU - Algren, D. A.

AU - Alwasiyah, D.

AU - Beauchamp, G.

AU - Bentur, Y.

AU - Beuhler, M. C.

AU - Boyle, K. L.

AU - Bruccoleri, R. E.

AU - Burns, M. M.

AU - Cahana, A.

AU - Cannon, R. D.

AU - Caravati, E. M.

AU - Carey, J. L.

AU - Chhabra, N.

AU - Chomin, J.

AU - Christian, M. R.

AU - Conner, K.

AU - Cook, M. D.

AU - Cumpston, K. L.

AU - Dissanayake, V.

AU - Dribben, W. H.

AU - Eisenga, B. H.

AU - Engebretsen, K. M.

AU - Falkowitz, D.

AU - Farkas, A.

AU - Fenton, A.

AU - Froberg, B. A.

AU - Furmaga, J. F.

AU - Ganetsky, M.

AU - Garlich, F.

AU - Geib, A. J.

AU - Gorodetsky, R.

AU - Greene, S.

AU - Greller, H. A.

AU - Gummin, D. D.

AU - Hart, K.

AU - Hendrickson, R. G.

AU - Hernandez, S.

AU - Hoyte, C. O.

AU - Kirschner, Ronald I

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The Toxicology Investigators Consortium (ToxIC) Case Registry was established by the American College of Medical Toxicology in 2010. The Registry contains data from participating sites with the agreement that all bedside medical toxicology consultations will be entered. Currently, 83% of accredited medical toxicology fellowship programs in the USA participate. The Registry continues to grow each year, and as of 31 December 2016, a new milestone was reached, with more than 50,000 cases reported since its inception. The objective of this seventh annual report is to summarize the Registry’s 2016 data and activity with its additional 8529 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2016. Detailed data was collected from these cases and aggregated to provide information which includes the following: demographics (age, gender, race, ethnicity, HIV status), reason for medical toxicology evaluation (intentional pharmaceutical exposure, envenomation, withdrawal from a substance), agent and agent class, clinical signs and symptoms (vital sign abnormalities, organ system dysfunction), treatments and antidotes administered, fatality and life support withdrawal data. Fifty percent of cases involved females, and adults aged 19–65 were the most commonly reported. There were 86 patients (1.0%) with HIV-positive status known. Non-opioid analgesics were the most commonly reported agent class, with acetaminophen the most common agent reported. There were 126 fatalities reported in 2016 (1.5% of cases). Major trends in demographics and exposure characteristics remained similar overall with past years’ reports. While treatment interventions were commonly required, fatalities were rare.

AB - The Toxicology Investigators Consortium (ToxIC) Case Registry was established by the American College of Medical Toxicology in 2010. The Registry contains data from participating sites with the agreement that all bedside medical toxicology consultations will be entered. Currently, 83% of accredited medical toxicology fellowship programs in the USA participate. The Registry continues to grow each year, and as of 31 December 2016, a new milestone was reached, with more than 50,000 cases reported since its inception. The objective of this seventh annual report is to summarize the Registry’s 2016 data and activity with its additional 8529 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2016. Detailed data was collected from these cases and aggregated to provide information which includes the following: demographics (age, gender, race, ethnicity, HIV status), reason for medical toxicology evaluation (intentional pharmaceutical exposure, envenomation, withdrawal from a substance), agent and agent class, clinical signs and symptoms (vital sign abnormalities, organ system dysfunction), treatments and antidotes administered, fatality and life support withdrawal data. Fifty percent of cases involved females, and adults aged 19–65 were the most commonly reported. There were 86 patients (1.0%) with HIV-positive status known. Non-opioid analgesics were the most commonly reported agent class, with acetaminophen the most common agent reported. There were 126 fatalities reported in 2016 (1.5% of cases). Major trends in demographics and exposure characteristics remained similar overall with past years’ reports. While treatment interventions were commonly required, fatalities were rare.

KW - Epidemiology

KW - Medical toxicology

KW - Overdose

KW - Poisonings

UR - http://www.scopus.com/inward/record.url?scp=85026538607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026538607&partnerID=8YFLogxK

U2 - 10.1007/s13181-017-0627-3

DO - 10.1007/s13181-017-0627-3

M3 - Article

VL - 13

SP - 203

EP - 226

JO - Journal of Medical Toxicology

JF - Journal of Medical Toxicology

SN - 1556-9039

IS - 3

ER -